UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Jeffrey M. Miller, M.D.

Specialty:

Hematology/Oncology

General Information:

Gender:	Male
Language(s):	English

Affiliation(s):

Assistant Clinical Professor, David Geffen School of Medicine, Olive View-UCLA Medical Center, Division of Hematology/Oncology

Member, JCCC Cancer and Stem Cell Biology Program Area

Hospital Affiliation(s):

Olive View-UCLA Medical Center

Education:

Fellowship:	Hematology/Oncology, University of Maryland Cancer Center, 1991 - 1994
Residency:	Seton Hall University, 1988 - 1991
Medical Degree:	M.D., Ross University, 1988

Certification(s):

Medical Board Certification(s):	Internal Medicine, American Board of Internal Medicine, 1991, 2005 Hematology, 1994, 2005 Medical Oncology, 1995, 2005

Contact Information:

Phone:	(818) 364-3205
Email:	jemiller@dhs.lacounty.gov

Scientific Interest(s):

Dr. Jeffrey M. Miller is interested in hematologic malignancies, general oncology, and clinical trials.

Selected Cancer-Related Publications:

Lipshutz GS, Pham PC, Ghobrial MR, Wallace WD, Miller JM, Pham PT. Thrombotic microangiopathy following pancreas after kidney transplants. Clin Transplant. 2008 Mar-Apr;22(2):236-41.

Pham PT, Pham PM, Miller JM, Pham PC. Polyclonal antibody-induced serum sickness presenting as rapidly progressive descending paralysis. Transplantation. 2007 Jun 27;83(12):1657.

Pham PT, Wilkinson AH, Gritsch HA, Pham PC, Miller JM, Lassman CR, Danovitch GM. Monotherapy with the anti-CD20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease. Transplant Proc. 2002 Jun;34(4):1178-81.

Pham PT, Miller JM, Demetrion G, Lew SQ. Clotting by heparin of hemoaccess for hemodialysis in an end-stage renal disease patient. Am J Kidney Dis. 1995 Apr;25(4):642-7.